Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults

DSpace Repository

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults

Author: Tandler, Claudia; Heitmann, Jonas S.; Michel, Tanja M.; Marconato, Maddalena; Jaeger, Simon U.; Tegeler, Christian M.; Denk, Monika; Richter, Marion; Oezbek, Melek Tutku; Maringer, Yacine; Schroeder, Sarah M.; Schneiderhan-Marra, Nicole; Wiesmueller, Karl-Heinz; Bitzer, Michael; Ruetalo, Natalia; Schindler, Michael; Meisner, Christoph; Fischer, Imma; Rammensee, Hans-Georg; Salih, Helmut R.; Walz, Juliane S.
Tübinger Autor(en):
Tandler, Claudia
Heitmann, Jonas S.
Marconato, Maddalena
Tegeler, Christian M.
Denk, Monika
Richter, Marion
Maringer, Yacine
Schneiderhan-Marra, Nicole
Bitzer, Michael
Ruetalo, Natalia
Schindler, Michael
Fischer, Imma
Rammensee, Hans-Georg
Salih, Helmut R.
Walz, Juliane S.
Michel, Tanja
Jäger, Simon U.
Özbek, Melek Tutku
Schröder, Sarah Marena
Published in: International Journal of Infectious Diseases (2024), Bd. 139, S. 69-77
Verlagsangabe: London : Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.ijid.2023.11.009
ISSN: 1201-9712
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)